Fundz

Cerenome Appoints Ron Andrews as Chief Business Officer

PUBLIC · CNSYNov 10, 2026
Internal move“Mr. Andrews will continue to serve on the Company's Board of Directors.”

Position

Chief Business Officer

Company

Cerenome, Inc.

Ron 'Ronnie' Andrews
HoustonManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalHealth Diagnostics

Description

Cerenome, Inc. has announced the appointment of Ron 'Ronnie' Andrews as Chief Business Officer, a newly created position aimed at advancing the company's business development and commercial strategy. Mr

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Cerenome, Inc., and when

A new leader at Cerenome, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cerenome, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cerenome, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cerenome, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cerenome, Inc.

Location

6420 Levit Green Boulevard

Houston, Texas, United States

About

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for patients. Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). The Company has built a supply chain through strategic partnerships that enable the development, manufacturing and future potential commercialization of its products. Plus Therapeutics is led by an experienced and dedicated leadership team and has operations in key cancer clinical development hubs, including Austin and San Antonio, Texas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cerenome, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Charles
Senior decision-maker at this company
••••••••@••••••••

See Charles's verified email →

Mia
Senior decision-maker at this company
••••••••@••••••••

See Mia's verified email →

Marc
Senior decision-maker at this company
••••••••@••••••••

See Marc's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cerenome, Inc.'s next move

Learn about Strategic plan

Cerenome, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.